Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,863.00
Bid: 2,869.00
Ask: 2,871.00
Change: -22.00 (-0.76%)
Spread: 2.00 (0.07%)
Open: 2,892.00
High: 2,896.00
Low: 2,847.00
Prev. Close: 2,885.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Dec 2021 07:00

RNS Number : 5103V
3i Group PLC
14 December 2021
 

Appointment of Chief Operating Officer

 

3i Group PLC ("3i Group" or the "Company") announces that Ms Jasi Halai, currently Group Financial Controller, will join the Group Board as Chief Operating Officer in May 2022. She will also join the Executive Committee.

 

Ms Halai joined 3i in 2005 and has held a variety of posts in the business, most recently as Group Financial Controller and Operating Officer.

 

David Hutchison, Chairman of 3i Group, said:

"We are delighted to announce Jasi's promotion to the Board as Chief Operating Officer She has played an important Group role for a number of years managing the Group's central financial operations and we look forward to her contribution to the Board over the coming years."

 

Simon Borrows, CEO of 3i Group, said:

"I am very pleased that Jasi is being appointed to the Board as Chief Operating Officer. As well as continuing her role managing the Group's central finance and operations functions she will also take on responsibility for the Group's IT, property and procurement activities. Jasi will work closely with James Hatchley when he succeeds Julia Wilson as Group Finance Director in May next year."

 

-Ends-

 

For further information, contact:

 

Kathryn van der KroftCommunications Director

 

020 7975 3021

Silvia SantoroGroup Investor Relations Director

 

020 7975 3258

 

 

Notes to Editors

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com

 

Additional information - Jasi Halai

Prior to joining 3i Jasi Halai held positions at CDC and Actis. She is also a non-executive director at Porvair Plc, and is a member of the Chartered Institute of Management Accountants and holds an MSc in investment management from the CASS Business School.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATJBMTMTMBTRB
Date   Source Headline
28th Feb 20222:44 pmRNSDirector/PDMR Shareholding
4th Feb 20221:08 pmRNSDirector/PDMR Shareholding
31st Jan 20225:18 pmRNSTotal Voting Rights
31st Jan 20225:16 pmRNSDirector/PDMR Shareholding
27th Jan 20227:00 amRNSQ3 Performance update
5th Jan 20225:00 pmRNSTotal Voting Rights
5th Jan 20224:58 pmRNSDirector/PDMR Shareholding
4th Jan 20229:43 amRNSPortfolio Update
16th Dec 20217:00 amRNSDirector Declaration
14th Dec 20217:00 amRNSDirectorate Change
9th Dec 202110:57 amRNSBlock listing Interim Review
30th Nov 20213:53 pmRNSTotal Voting Rights
30th Nov 20213:52 pmRNSDirector/PDMR Shareholding
30th Nov 202111:53 amRNSDirector/PDMR Shareholding
11th Nov 202111:05 amRNSDirectorate Change
11th Nov 20219:52 amRNSDoc re. Half Yearly Report 2021
11th Nov 20217:02 amRNSGroup Finance Director succession
11th Nov 20217:00 amRNSResults for the six months to 30 September 2021
3rd Nov 20211:44 pmRNSHolding(s) in Company
2nd Nov 20217:30 amRNS3i portfolio company Action announces new CEO
29th Oct 20212:29 pmRNSTotal Voting Rights
29th Oct 20212:22 pmRNSDirector/PDMR Shareholding
1st Oct 202112:59 pmRNSDirector/PDMR Shareholding
1st Oct 202110:04 amRNSPortfolio Update
30th Sep 20214:16 pmRNSTotal Voting Rights
30th Sep 20214:15 pmRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSDirectorate Change
29th Sep 20212:25 pmRNSDirector/PDMR Shareholding
28th Sep 20219:27 amRNSDirector/PDMR Shareholding
27th Sep 20217:00 amRNSUpdate on portfolio and Capital Markets Seminar
21st Sep 202112:27 pmRNSDirector/PDMR Shareholding
31st Aug 20214:00 pmRNSTotal Voting Rights
31st Aug 20213:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:25 amRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jul 20214:05 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSFY2022 Q1 performance update
1st Jul 20213:14 pmRNSDirector/PDMR Shareholding
1st Jul 20213:07 pmRNSDirector/PDMR Shareholding
1st Jul 202111:47 amRNSResult of AGM
1st Jul 202111:42 amRNSDoc re. AGM Resolutions
1st Jul 20219:59 amRNSPortfolio Update
30th Jun 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20214:09 pmRNSTotal Voting Rights
30th Jun 20214:04 pmRNSDirector/PDMR Shareholding
29th Jun 20212:24 pmRNSDirector/PDMR Shareholding
29th Jun 20211:55 pmRNSDirector/PDMR Shareholding
10th Jun 202110:55 amRNSBlock listing Interim Review
8th Jun 20212:25 pmRNSDirector/PDMR Shareholding
4th Jun 20212:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.